{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "", "headline": {"main": "Did Colorado Go Too Far With Pot?", "kicker": "Room For Debate"}, "abstract": "Was the move to legalize marijuana done too quickly? Do changes need to be made to their approach?", "print_page": null, "word_count": "2589", "_id": "53910966798810048190626b", "snippet": "Was the move to legalize marijuana done too quickly? Do changes need to be made to their approach?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/roomfordebate/2014/06/05/did-colorado-go-too-far-with-pot/", "multimedia": [], "subsection_name": "Room For Debate", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2014-06-05T18:37:13Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Former Pro Bowl defender Marcellus Wiley added his name to a lawsuit accusing NFL teams of illegally dispensing powerful narcotics and other drugs to keep players on the field without regard for their long-term health.", "headline": {"main": "Second Wave of Former Players Join NFL Lawsuit", "print_headline": "Second Wave of Former Players Join NFL Lawsuit"}, "abstract": null, "print_page": null, "word_count": "740", "_id": "538f54d679881020af4fb336", "snippet": "Former Pro Bowl defender Marcellus Wiley added his name to a lawsuit accusing NFL teams of illegally dispensing powerful narcotics and other drugs to keep players on the field without regard for their long-term health.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/06/04/us/ap-fbn-nfl-drug-lawsuit.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-06-04T13:16:51Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "The Fight Against Fake Drugs", "kicker": "Fixes"}, "abstract": "An ingenious cellphone verification system is just one of the methods being used to combat deadly counterfeit medications in Africa.", "print_page": null, "word_count": "1632", "_id": "538f34d6798810528a32833e", "snippet": "An ingenious cellphone verification system is just one of the methods being used to combat deadly counterfeit medications in Africa.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2014/06/04/the-fight-against-fake-drugs/", "multimedia": [{"subtype": "thumbnail", "url": "images/2014/04/25/opinion/opinionator-pog-fixes/opinionator-pog-fixes-thumbStandard.gif", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/04/25/opinion/opinionator-pog-fixes/opinionator-pog-fixes-thumbStandard.gif", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Labeling and Labels", "name": "subject", "rank": "3"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "Text Messaging", "name": "subject", "rank": "4"}, {"value": "Counterfeit Merchandise", "name": "subject", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tina", "lastname": "ROSENBERG"}], "original": "By TINA ROSENBERG"}, "document_type": "blogpost", "pub_date": "2014-06-04T11:00:32Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Enforcement of Arizona regulations curbing access to abortion-inducing drugs by prohibiting off-label uses of the medication will remain on hold while a legal challenge to those rules proceeds under judicial review, a federal appeals court ruled on Tuesday.", "headline": {"main": "Arizona Abortion Drug Restrictions to Stay Blocked Pending Appeal", "print_headline": "Arizona Abortion Drug Restrictions to Stay Blocked Pending Appeal"}, "abstract": null, "print_page": null, "word_count": "380", "_id": "538e23a5798810528a328049", "snippet": "Enforcement of Arizona regulations curbing access to abortion-inducing drugs by prohibiting off-label uses of the medication will remain on hold while a legal challenge to those rules proceeds under judicial review, a federal appeals court ruled on...", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/06/03/us/03reuters-usa-abortion-arizona.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-06-03T15:33:36Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "The city of Chicago has filed a lawsuit against five large narcotics makers alleging they contributed to the country&#8217;s prescription drug epidemic by deceptively promoting their painkillers. ", "headline": {"main": "Chicago Sues Painkiller Makers for Deceptive Marketing", "print_headline": "Chicago Sues Painkiller Makers for Deceptive Marketing"}, "abstract": null, "print_page": null, "word_count": "491", "_id": "538e1b2e798810528a32802d", "snippet": "The city of Chicago has filed a lawsuit against five large narcotics makers alleging they contributed to the country&#8217;s prescription drug epidemic by deceptively promoting their painkillers.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/06/03/world/middleeast/03reuters-usa-drugs-lawsuit.html", "multimedia": [], "subsection_name": "Middle East", "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-06-03T14:57:08Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "The nation's strictest rules on the use of abortion drugs are likely to be struck down and will continue to be blocked while a lawsuit against them plays out, a federal appeals court ruled Tuesday.", "headline": {"main": "Arizona Abortion Restrictions to Remain Blocked", "print_headline": "Arizona Abortion Restrictions to Remain Blocked"}, "abstract": null, "print_page": null, "word_count": "710", "_id": "538e06f8798810528a327fe3", "snippet": "The nation's strictest rules on the use of abortion drugs are likely to be struck down and will continue to be blocked while a lawsuit against them plays out, a federal appeals court ruled Tuesday.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/06/03/us/ap-us-abortion-restrictions.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-06-03T13:31:32Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": "Business", "lead_paragraph": null, "headline": {"main": "Morning Agenda: France's Direct Appeal on Bank", "kicker": "DealBook"}, "abstract": "French officials are appealing to the United States on behalf of BNP Paribas. | Valeant\u2019s bid for Allergan raises a question about the role of drug companies. | Pilgrim\u2019s Pride raises its bid for Hillshire Brands. | Trouble may be brewing at Salesforce.", "print_page": null, "word_count": "1888", "_id": "538db470798810066d972ed7", "snippet": "French officials are appealing to the United States on behalf of BNP Paribas. | Valeant\u2019s bid for Allergan raises a question about the role of drug companies. | Pilgrim\u2019s Pride raises its bid for Hillshire Brands. | Trouble may be brewing at...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dealbook.nytimes.com/2014/06/03/morning-agenda-frances-direct-appeal-on-bank/", "multimedia": [], "subsection_name": "Dealbook", "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sydney", "lastname": "EMBER"}], "original": "By SYDNEY EMBER"}, "document_type": "blogpost", "pub_date": "2014-06-03T07:40:15Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Words matter. Putting a label on normal variations of physiology can cause needless worry, spending and even bodily harm.", "headline": {"main": "Calling an Ordinary Health Problem a Disease Leads to Bigger Problems", "kicker": "The Upshot", "print_headline": "The Trouble With Labeling a Health Problem a Disease", "content_kicker": "The New Health Care"}, "abstract": "The Upshot; labeling of patients with a 'disease' can have significant consequences; putting a label on normal variations of physiology can cause needless worry, spending and even bodily harm.", "print_page": "3", "word_count": "821", "_id": "538c529379881044f484dab8", "snippet": "Words matter. Putting a label on normal variations of physiology can cause needless worry, spending and even bodily harm.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/03/upshot/calling-an-ordinary-health-problem-a-disease-leads-to-bigger-problems.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/02/upshot/02UP-disease/02UP-disease-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/02/upshot/02UP-disease/02UP-disease-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/02/upshot/02UP-disease/02UP-disease-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/02/upshot/02UP-disease/02UP-disease-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/02/upshot/02UP-disease/02UP-disease-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/02/upshot/02UP-disease/02UP-disease-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Babies and Infants", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Parenting", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"firstname": "Aaron", "middlename": "E.", "lastname": "CARROLL", "rank": 1, "role": "reported", "organization": ""}], "original": "By AARON E. CARROLL"}, "document_type": "article", "pub_date": "2014-06-03T00:00:00Z", "section_name": "The Upshot"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Adult deaths and children\u2019s emergency room visits in Colorado are being linked to newly legal marijuana, often in its edible form, and opponents of legalization are warning other states to pay heed.", "headline": {"main": "After 5 Months of Sales, Colorado Sees the Downside of a Legal High", "print_headline": "After 5 Months of Sales, Colorado Sees the Downside of a Legal High"}, "abstract": "Battle over legalization of recreational marijuana sales in Colorado is still raging, five months after it was enacted; adult deaths and children\u2019s emergency room visits in state are being linked to potent doses of newly legal marijuana, often in its edible form, and opponents of legalization are warning other states to pay heed.", "print_page": "14", "word_count": "1412", "_id": "538a74ea79881007af366a4a", "snippet": "Adult deaths and children\u2019s emergency room visits in Colorado are being linked to newly legal marijuana, often in its edible form, and opponents of legalization are warning other states to pay heed.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/01/us/after-5-months-of-sales-colorado-sees-the-downside-of-a-legal-high.html", "multimedia": [{"subtype": "wide", "url": "images/2014/05/31/us/JP-MARIJUANA2/JP-MARIJUANA2-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/05/31/us/JP-MARIJUANA2/JP-MARIJUANA2-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/05/31/us/JP-MARIJUANA2/JP-MARIJUANA2-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/05/31/us/JP-MARIJUANA2/JP-MARIJUANA2-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/05/31/us/JP-MARIJUANA3/JP-MARIJUANA3-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/05/31/us/JP-MARIJUANA3/JP-MARIJUANA3-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Children and Childhood", "is_major": "Y", "rank": "8", "name": "subject"}, {"value": "Deaths (Fatalities)", "is_major": "Y", "rank": "10", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Colorado", "is_major": "Y", "rank": "4", "name": "glocations"}, {"value": "Crime and Criminals", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Marijuana", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Traffic Accidents and Safety", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Emergency Medical Treatment", "is_major": "Y", "rank": "9", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Jack", "lastname": "HEALY"}], "original": "By JACK HEALY"}, "document_type": "article", "pub_date": "2014-06-01T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial", "lead_paragraph": "Too often, companies hide dangers from regulators by reaching legal settlements that are conditioned on silence.", "headline": {"main": "Secrecy That Kills", "kicker": "Editorial", "print_headline": "Secrecy That Kills", "content_kicker": "Editorial"}, "abstract": "Editorial decries corporate practice of reaching legal settlements with victims that include conditions of silence, such as those that allowed General Motors to hide lethal flaws in ignition switches for more than a decade; supports legislation that would make it harder for companies to hide behind private agreements with plaintiffs.", "print_page": "10", "word_count": "478", "_id": "538a1fae79881007af366986", "snippet": "Too often, companies hide dangers from regulators by reaching legal settlements that are conditioned on silence.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/01/opinion/sunday/secrecy-that-kills.html", "multimedia": [], "subsection_name": "Sunday Review", "keywords": [{"value": "House of Representatives", "is_major": "N", "rank": "11", "name": "organizations"}, {"value": "Senate", "is_major": "N", "rank": "12", "name": "organizations"}, {"value": "General Motors", "is_major": "Y", "rank": "5", "name": "organizations"}, {"value": "Graham, Lindsey", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Defective Products", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Deaths (Fatalities)", "is_major": "N", "rank": "9", "name": "subject"}, {"value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Suits and Litigation (Civil)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Blumenthal, Richard", "is_major": "N", "rank": "2", "name": "persons"}, {"value": "Editorials", "is_major": "Y", "rank": "13", "name": "subject"}, {"value": "Liability for Products", "is_major": "Y", "rank": "10", "name": "subject"}, {"value": "Automobile Safety Features and Defects", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [], "original": "By THE EDITORIAL BOARD", "organization": "THE EDITORIAL BOARD"}, "document_type": "article", "pub_date": "2014-06-01T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 10, "offset": 0, "time": 53}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}